Front Range Biosciences raises $8.5M to support growth
LAFAYETTE — Front Range Biosciences Inc., an agricultural biotech company focused on high-value crops such as cannabis, announced Monday that it has raised $8.5 million from existing investors.
Those investors include Militello Capital, Welcan Capital, AFI Capital, Phyto Partners, Harvard Business School Alumni Angels of New York, New York Angels, Sand Hill Angels XVI LLC, Arcadian Capital Management, Halley Venture Partners LP and Salveo Capital, according to a Front Range Biosciences news release.
The funding will help Front Range Biosciences expand its Clean Stock program, which uses tissue-culture technology to provide growers with genetically optimized hemp and cannabis plants.
The company’s latest fundraising…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Tilled Inc., a Boulder payment-facilitation technology company, recently completed a $12.5 million investment round, bringing…
-
Brightwave, Boulder-based AI technology company is “swinging for the fences,” after raising $21 million to…
-
Downtown Boulder’s Business Improvement District is recruiting two at-large board members.
-
The Nest Schools will continue its expansion in Colorado with its seventh location set to…
